Bausch Health Companies | Umsatzkosten



Cost Of Sales Veränderung Datum
Amgen USD 2.6B 507M 2025-03
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
Aurora Cannabis CAD 78.85M 891K 2024-12
Bausch Health Companies USD 701M 26M 2025-03
Biogen USD 629.3M 45.8M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.4M 553K 2025-03
Danaher USD 2.23B 418M 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Novo Nordisk 12.89B 1.58B 2025-03
Pacira USD 34.31M 5.58M 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Prestige Brands USD 126.51M 2.76M 2025-03
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zoetis USD 622M 85M 2025-03



Bausch Health Companies Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.